• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

RenalGuard Solutions

BD lifts Bard vet DeFord to CTO | Personnel Moves – June 4, 2018

June 4, 2018 By Fink Densford

Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company […]

Filed Under: Business/Financial News Tagged With: becton dickinson, C.R. Bard, Cook Medical, ectosense, integer, meddux, Merit Medical Systems, Nuvasive, Optovue, polarityte, RenalGuard Solutions, Teleflex, Vital Connect

RenalGuard touts ADHF treatment feasibility study data

May 29, 2018 By Fink Densford

RenalGuard Solutions late last week released results from a feasibility study of its RenalGuard-guided diuretic therapy intended to improve fluid management in patients with acute decompensated heart failure and alleviate related symptoms. Results from the study were presented at the European Society of Cardiology’s Heart Failure 2018 conference in Vienna, the Milford, Mass.-based company said. […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: RenalGuard Solutions

RenalGuard Solutions touts first-in-man heart failure device study results

January 2, 2018 By Fink Densford

RenalGuard Solutions today touted results from a first-in-man feasibility study of its RenalGuard System designed to manage fluids during diuretic therapy to treat congestive heart failure in patients suffering from fluid overload. Results from the trial were presented at the annual Devices in Heart Failure congress in Berlin, Germany, the Milford, Mass.-based company said. The […]

Filed Under: Cardiovascular, Clinical Trials Tagged With: RenalGuard Solutions

7 medtech stories we missed this week: Oct. 20, 2017

October 20, 2017 By Danielle Kirsh

From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD inks Chile distribution deal InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime […]

Filed Under: 510(k), Cardiovascular, Clinical Trials, Diagnostics, Food & Drug Administration (FDA), Implants, Orthopedics, Patient Monitoring, Regulatory/Compliance, Surgical, Ultrasound Tagged With: Esaote, Hillrom, Honeywell, InspireMD, Medacta, MedTech, RenalGuard Solutions, Subchondral Solutions, Vivasure, Welch Allyn

Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017

July 12, 2017 By Fink Densford

Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]

Filed Under: Business/Financial News Tagged With: Abiomed, Accuray Inc., Amendia, Boston Scientific, C.R. Bard, Cochlear Ltd., conformis, GE Healthcare, InVivo Corp., IsoRay, Johnson and Johnson, Lidco, Lumicell, Neurometrix, Philips, portal instruments, RenalGuard Solutions, Sanofi-Aventis, Spinal Elements, stjudemedical, Stryker, TherOx Inc, Zimmer Biomet

RenalGuard reels in $15m Series A

March 16, 2017 By Brad Perriello

RenalGuard Solutions said today that it raised a $14.5 million Series A round for a pivotal trial of its device to prevent acute kidney injury during percutaneous procedures. The Milford, Mass.-based company’s eponymous device is designed to measure urine output and automatically infuse hydration fluid based on those measurements. It aims to induce high urine rates to protect […]

Filed Under: Cardiovascular, Funding Roundup, Wall Street Beat Tagged With: RenalGuard Solutions

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS